Invention Grant
- Patent Title: Quinazolin-4 (3H)-one derivatives used as P13 kinase inhibitors
-
Application No.: US15092707Application Date: 2016-04-07
-
Publication No.: US09637494B2Publication Date: 2017-05-02
- Inventor: John King-Underwood , Kazuhiro Ito , Peter John Murray , George Hardy , Frederick Arthur Brookfield , Christopher John Brown
- Applicant: Respivert Ltd
- Applicant Address: GB Buckinghamshire
- Assignee: Respivert, Ltd.
- Current Assignee: Respivert, Ltd.
- Current Assignee Address: GB Buckinghamshire
- Agent Ada O. Wong
- Priority: TW099135360A 20101018; WOPCT/EP2010/065746 20101019
- Main IPC: A01N43/90
- IPC: A01N43/90 ; A61K31/519 ; C07D487/04
Abstract:
The present invention relates to the compound of formula (I) and to compositions comprising the same and to the use of the compound and to compositions of the compound in treatment, for example in the treatment of inflammatory diseases, in particular respiratory inflammatory disease. The invention also extends to methods of making the said compound.
Public/Granted literature
- US20160222019A1 QUINAZOLIN-4 (3H)- ONE DERIVATIVES USED AS P13 KINASE INHIBITORS Public/Granted day:2016-08-04
Information query
IPC分类:
